Title: Study on Levels of Glycosylated Haemoglobin and Urinary Microalbumin in Diabetic Cases and Healthy Controls
Authors: Alokananda Purkayastha, Mauchumi Saikia Pathak, Shafique Ahmed
DOI: https://dx.doi.org/10.18535/jmscr/v5i3.163
Abstract
Diabetes is one of the most common endocrine disorders characterized by hyperglycaemia. Diabetic nephropathy is a consequence of long standing diabetes. The prevalence of microalbuminuria predicts progression to diabetic nephropathy. The present study was conducted to determine the prevalence of microalbuminuria in relation to HbA1c in Diabetic cases in comparison to healthy controls.
Objective of the study: Lots of studies have been conducted on the levels of microalbumin and HbA1c in a patient with diabetes mellitus. Since the role of these parameters are increasingly reviewed and evaluated, the need to carry out further such studies become obvious. The present study is thus designed to evaluate the role of microalbumin and glycated haemoglobin in predicting incipient nephropathy in diabetics so as to prevent the onset of overt nephropathy
Materials and Methods: This case-control descriptive study was carried out in a Silchar Medical College And Hospital from July2013 to july2014. One hundred known diabetic patients with age 21–90 years were included in the study. Informed consent and a structured questionnaire of each patient were recorded. Fasting venous blood and morning urine sample was collected for analysis of Fasting blood glucose, HbA1c and urinary microalbumin respectively. Statistical analysis was done using graph stat statistical software.
All p-values <0.05 were considered as statistically significant.
Results: Fasting blood glucose levels , urinary microalbumin, and blood HbA1C levels were very high in diabetic cases as compared to healthy controls ( p- value 0.0). Also the urinary microalbumin levels were very high in the diabetic cases with poor glycaemic control.
Conclusion: The present study found higher level of HbA1C and urinary microalbumin level in diabetics. Also high level of microalbuminuria in the cases which could be due to poor glycaemic control (high HbA1C >7%). Screening for microalbuminuria and HbA1c test should be done in both newly and already diagnosed diabetic patients as an early marker of renal dysfunction and glycaemic control.
References
1. Alvin C Powers, Dennis L Kasper, Eugene Braunwald, Anthony Fauci,Stephen Hauser, Dan Longo, J Harry Lameson. Harrisons Principle Of InternalMedicine, (17th Edition):2008; p1791, 2275
2. Anonymous (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl 1):S5–S20
3. World Health Organization (2008) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia . Available from www.who.int/diabetes/publications/en/, accessed 5 August 2008.
4. Powers A C. Diabetes Mellitus In: Jameson JL. (editor) Harrisons Endocri-nology 1st ed.New York McGraw-Hill; 2006; p303–304.
5. Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephro-pathy. J Am Soc Nephrol 2003;14: p1358-1373.
6. Vergouwe Y, Soedamah-Muthu SS, Zgibor J, Chaturvedi N, Forsblom C, Snell-Bergeon JK, et al. Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia 2010;53: p254-262.
7. Ritz E: Nephropathy in type 2 diabetes.Journal of Internal Medicine 245:111–126,1999
8. Alzaid AA: Microalbuminuria in patients with NIDDM: an overview (Review). Diabetes Care 19:79–89, 1996
9. American Diabetes Association: Diabetic nephropathy (Position Statement). Diabe-tes Care 23 (Suppl. 1):S69 –S72, 2000
10. Mogensen CE: Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia42:263–285, 1999
11. Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulus A, KeenH: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet i:1430 –1432, 1982
12. Andersen AR,Christiansen JS, Andersen JK, Kreiner S,Deckert T. Diabetic nephropathy in type 1 (insulin dependent) diabetes: an epidemiological study. Diabetologia 1983; 25: 496–501.
13. Borch-Johnsen K, Andersen JK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin dependent) diabetes mellitus. Diabetologia 1985; 28:590– 596
14. Justesen TI, Petersen JLA, Ekbom P, Damm P, Mathiesen ER. Albumin-to-Creatinine ratio in random urine samples might replace 24-h urine collections in screening for Micro-and Macroalbu-minuria in pregnant woman with Type 1 diabetes. Diabetes Care 2006;29:924–5.
15. Mogensen CE, Christensen CK. Predicting nephropathy in insulin dependent patients. N Engl J Med 1984;311:89–93.
16. Andrzej S, Krowlewski MD, Lori MB, Laffel MD, Krowlewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin dependent diabetes mellitus. N Engl J Med 1993;329: 977–86.
17. The Diabetes Control and Complications Trial Research Group. The effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 1995 :47: 1705–20.
18. Mogensen CE, Keane WF, Bennet PH, Jerums G, Parving HH, Passa P, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995;346:1080–4.
19. Rowe DJF, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine. Ann Clin Biochem 1990;27: 297–312.
20. http://en.wikipedia.org/wiki/Microalbuminuria
21. McCance DR, Hanson RL, Charles MA et al (1994); Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ1994; 308:p1323–1328.
22. American Diabetes Association (2007) Standards of medical care in diabetes– Diabetes Care 2007; 30:S4–S41.
23. Tapp RJ, Zimmet PZ, Harper CA et al . Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract2006; 73:p315–321.
24. Anonymous The effect of intensive treatment of diabetes on the development and progression of long-term complicat-ions in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group. N Engl J Med1993; 329:p977–986.
25. Anonymous Intensive blood-glucose con-trol with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UK Prospective Diabetes Study (UKPDS) Group. Lancet1998; 352:p837–853.
26. Ito C, MaedaR, Ishida S, Sasaki H, Harada. Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT& HbA1c. Diabetes Res Clin Pract2000; 50:p225–230.
27. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB . A new look at screening and diagnosing diabetes mellitus. J.Clin Endocrinol Metab2008; 93:p2447–2453.
28. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med2002;137:p263–272
29. Gupta, D.K.; Verma, L.K. and Khosla, P.K.The prevalence of microalbuminuria in diabetes: a study from north India. Diabetes Res Clin Pract,1991; 12: 125-8.
30. Allawi, J., Rao P.V., Gilbert, R. Microalbuminuria in non- insulin – dependent diabetes : Its prevalence in Indian compared with Europid patients. Br. Med. J. 1988, 296;462 – 464.
31. Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C. Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163.
32. Kumar PR, Bhansali A, Ravikiran M et al. Utility of Glycated Hemoglobin in diagnosing Type 2 diabetes mellitus: A community based study. J Clin Endocrinol Metab 2010;95:2832-5.
33. Carson AP, Reynolds K, Fonseca VA et al. Comparison of A1c and fasting glucose criteria to diagnose diabetes amongst US adults. Diabetes Care 2010:33:95-7.